Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy

Abstract Background Accumulating evidence suggest that autophagy plays a pivotal role in various anticancer therapies, including photodynamic therapy (PDT), acting as a pro-death or pro-survival mechanism in a context-dependent manner. Therefore, we aimed to determine the role of autophagy in Photof...

Full description

Bibliographic Details
Main Authors: Antoni Domagala, Joanna Stachura, Magdalena Gabrysiak, Angelika Muchowicz, Radoslaw Zagozdzon, Jakub Golab, Malgorzata Firczuk
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-018-4126-y
_version_ 1818668662207283200
author Antoni Domagala
Joanna Stachura
Magdalena Gabrysiak
Angelika Muchowicz
Radoslaw Zagozdzon
Jakub Golab
Malgorzata Firczuk
author_facet Antoni Domagala
Joanna Stachura
Magdalena Gabrysiak
Angelika Muchowicz
Radoslaw Zagozdzon
Jakub Golab
Malgorzata Firczuk
author_sort Antoni Domagala
collection DOAJ
description Abstract Background Accumulating evidence suggest that autophagy plays a pivotal role in various anticancer therapies, including photodynamic therapy (PDT), acting as a pro-death or pro-survival mechanism in a context-dependent manner. Therefore, we aimed to determine the role of autophagy in Photofrin-based PDT. Methods In vitro cytotoxic/cytostatic effects of PDT were evaluated with crystal violet cell viability assay. Autophagy induction was analyzed by immunoblotting and immunofluorescence using anti-LC3 antibody. Autophagy was inhibited by shRNA-mediated ATG5 knockdown or CRISPR/Cas9-mediated ATG5 knockout. Apoptosis was assessed by flow cytometry analysis of propidium iodide and anexin V-positive cells as well as by detection of cleaved PARP and caspase 3 proteins using immunoblotting. Protein carbonylation was evaluated by the 2,4-dinitrophenylhydrazine (DNPH) method. Results Photofrin-PDT leads to robust autophagy induction in two cancer cell lines, Hela and MCF-7. shRNA-mediated knockdown of ATG5 only partially blocks autophagic response and only marginally affects the sensitivity of Hela and MCF-7 cells to PDT. ATG5 knockout in HeLa cell line utilizing CRISPR/Cas9 genome editing results in increased PDT-mediated cytotoxicity, which is accompanied by an enhanced apoptotic response and increased accumulation of carbonylated proteins. Conclusions Altogether, these observations imply that autophagy contributes to Photofrin-PDT resistance by enabling clearance of carbonylated and other damaged proteins. Therefore, autophagy inhibition may serve as a strategy to improve PDT efficacy.
first_indexed 2024-12-17T06:39:53Z
format Article
id doaj.art-16867412d425487fa07cdb3436c77e42
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-17T06:39:53Z
publishDate 2018-02-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-16867412d425487fa07cdb3436c77e422022-12-21T21:59:53ZengBMCBMC Cancer1471-24072018-02-0118111010.1186/s12885-018-4126-yInhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapyAntoni Domagala0Joanna Stachura1Magdalena Gabrysiak2Angelika Muchowicz3Radoslaw Zagozdzon4Jakub Golab5Malgorzata Firczuk6Department of Immunology, Medical University of WarsawDepartment of Immunology, Medical University of WarsawDepartment of Immunology, Medical University of WarsawDepartment of Immunology, Medical University of WarsawDepartment of Immunology, Medical University of WarsawDepartment of Immunology, Medical University of WarsawDepartment of Immunology, Medical University of WarsawAbstract Background Accumulating evidence suggest that autophagy plays a pivotal role in various anticancer therapies, including photodynamic therapy (PDT), acting as a pro-death or pro-survival mechanism in a context-dependent manner. Therefore, we aimed to determine the role of autophagy in Photofrin-based PDT. Methods In vitro cytotoxic/cytostatic effects of PDT were evaluated with crystal violet cell viability assay. Autophagy induction was analyzed by immunoblotting and immunofluorescence using anti-LC3 antibody. Autophagy was inhibited by shRNA-mediated ATG5 knockdown or CRISPR/Cas9-mediated ATG5 knockout. Apoptosis was assessed by flow cytometry analysis of propidium iodide and anexin V-positive cells as well as by detection of cleaved PARP and caspase 3 proteins using immunoblotting. Protein carbonylation was evaluated by the 2,4-dinitrophenylhydrazine (DNPH) method. Results Photofrin-PDT leads to robust autophagy induction in two cancer cell lines, Hela and MCF-7. shRNA-mediated knockdown of ATG5 only partially blocks autophagic response and only marginally affects the sensitivity of Hela and MCF-7 cells to PDT. ATG5 knockout in HeLa cell line utilizing CRISPR/Cas9 genome editing results in increased PDT-mediated cytotoxicity, which is accompanied by an enhanced apoptotic response and increased accumulation of carbonylated proteins. Conclusions Altogether, these observations imply that autophagy contributes to Photofrin-PDT resistance by enabling clearance of carbonylated and other damaged proteins. Therefore, autophagy inhibition may serve as a strategy to improve PDT efficacy.http://link.springer.com/article/10.1186/s12885-018-4126-yAutophagyPhotodynamic therapyPhotofrinATG5CRISR/Cas-9
spellingShingle Antoni Domagala
Joanna Stachura
Magdalena Gabrysiak
Angelika Muchowicz
Radoslaw Zagozdzon
Jakub Golab
Malgorzata Firczuk
Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy
BMC Cancer
Autophagy
Photodynamic therapy
Photofrin
ATG5
CRISR/Cas-9
title Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy
title_full Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy
title_fullStr Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy
title_full_unstemmed Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy
title_short Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy
title_sort inhibition of autophagy sensitizes cancer cells to photofrin based photodynamic therapy
topic Autophagy
Photodynamic therapy
Photofrin
ATG5
CRISR/Cas-9
url http://link.springer.com/article/10.1186/s12885-018-4126-y
work_keys_str_mv AT antonidomagala inhibitionofautophagysensitizescancercellstophotofrinbasedphotodynamictherapy
AT joannastachura inhibitionofautophagysensitizescancercellstophotofrinbasedphotodynamictherapy
AT magdalenagabrysiak inhibitionofautophagysensitizescancercellstophotofrinbasedphotodynamictherapy
AT angelikamuchowicz inhibitionofautophagysensitizescancercellstophotofrinbasedphotodynamictherapy
AT radoslawzagozdzon inhibitionofautophagysensitizescancercellstophotofrinbasedphotodynamictherapy
AT jakubgolab inhibitionofautophagysensitizescancercellstophotofrinbasedphotodynamictherapy
AT malgorzatafirczuk inhibitionofautophagysensitizescancercellstophotofrinbasedphotodynamictherapy